These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 699778

  • 1. [1st experiences with prostaglandin E1 long-term intra-arterial perfusion in advanced arterial occlusive disease of the lower extremities stage IV].
    Gruss JD, Kawai S, Karadedos C, Bartels D.
    Dtsch Med Wochenschr; 1978 Oct 13; 103(41):1624-5. PubMed ID: 699778
    [No Abstract] [Full Text] [Related]

  • 2. [Clinical experiences with prostaglandin E1 in severe peripheral artery disease].
    Carlson LA, Jogestrand T, Kaijser L, Olsson AG.
    Lakartidningen; 1977 Aug 03; 74(31):2629-33. PubMed ID: 895269
    [No Abstract] [Full Text] [Related]

  • 3. Treatment of peripheral arterial occlusive disease in stage IIb with intermittent short-term infusion of prostaglandin E1.
    Zanke BW, Hach W, Ozen Y, Sauerwein G.
    Vasa Suppl; 1987 Aug 03; 17():36-8. PubMed ID: 3470964
    [No Abstract] [Full Text] [Related]

  • 4. [Modification of collateral arteries by intra-arterial prostaglandin El infusion].
    Rudofsky G.
    Vasa Suppl; 1987 Aug 03; 20():215-7. PubMed ID: 3480596
    [No Abstract] [Full Text] [Related]

  • 5. Prostaglandin E1 in chronic arterial disease--a multicenter study.
    Trübestein G, Diehm C, Gruss JD, Horsch S.
    Vasa Suppl; 1987 Aug 03; 17():39-43. PubMed ID: 3470965
    [No Abstract] [Full Text] [Related]

  • 6. [Intravenous and intra-arterial prostaglandin E1 treatment in patients with stage IIb arterial occlusive disease].
    Rudofsky G.
    Vasa Suppl; 1988 Aug 03; 23():121-5. PubMed ID: 3206330
    [No Abstract] [Full Text] [Related]

  • 7. [Vital capillary microscopic examination and transcutaneous pO2-measurements by intravenous prostaglandin E1 infusion].
    Heidrich H, Lammersen T.
    Dtsch Med Wochenschr; 1985 Aug 23; 110(34):1283-5. PubMed ID: 4040847
    [Abstract] [Full Text] [Related]

  • 8. PGE1 in arterial occlusive disease stage III and IV.
    Bruch HP, Hörl M, Schindler G.
    Vasa Suppl; 1987 Aug 23; 17():26-31. PubMed ID: 3470962
    [No Abstract] [Full Text] [Related]

  • 9. Intravenous infusion of prostaglandin E1 (PGE1) in management of limb ischemia.
    Sethi GK, Bridgman AH, King L, Scott SM.
    Am Surg; 1986 Sep 23; 52(9):474-8. PubMed ID: 3752724
    [Abstract] [Full Text] [Related]

  • 10. [Intra-arterial administration of prostaglandin E1 in occlusive arterial diseases].
    Davidović L, Vranes M, Cernak I, Kostić D, Lovrić A, Sagić D, Lotina S.
    Srp Arh Celok Lek; 1992 Sep 23; 120(1-2):9-14. PubMed ID: 1641706
    [Abstract] [Full Text] [Related]

  • 11. Clinical effects of intravenously administered prostaglandin E1 in patients with rest pain due to peripheral obliterative arterial disease (POAD)--a preliminary report on a placebo-controlled double-blind study.
    Diehm C, Stammler F, Hübsch-Müller C, Eckstein HH, Simini B.
    Vasa Suppl; 1987 Sep 23; 17():52-6. PubMed ID: 3551154
    [No Abstract] [Full Text] [Related]

  • 12. Prostaglandin E1 as an adjuvant therapy in the event of femoropopliteal and crural great saphenous vein in situ bypass surgery.
    Fietze-Fischer B, Gruss JD, Bartels D, Vargas-Montano H, Stritter W.
    Vasa Suppl; 1987 Sep 23; 17():23-5. PubMed ID: 3470961
    [No Abstract] [Full Text] [Related]

  • 13. Intraarterial perfusion of prostaglandin E1 after lumbar sympathectomy or reconstruction on femoropopliteal segment.
    Davidovic LB, Vranes MR, Lotina SI, Cernak IF, Velimirovic DB, Stojanov PL, Sindjelic RP, Sagic DZ, Cinara IS.
    Int Angiol; 1991 Sep 23; 10(3):178-81. PubMed ID: 1765722
    [Abstract] [Full Text] [Related]

  • 14. Intra-arterial alprostadil for nonatherosclerotic vasculopathy.
    Wooster DL, Shamess CJ, Madras PN, Keystone EC.
    JAMA; 1981 May 08; 245(18):1846-9. PubMed ID: 7230371
    [Abstract] [Full Text] [Related]

  • 15. Conservative treatment of inoperable arterial occlusions of the lower extremities with intra-arterial prostaglandin E1.
    Gruss JD, Bartels D, Ohta T, Machado JL, Schlechtweg B.
    Br J Surg; 1982 Jun 08; 69 Suppl():S11-3. PubMed ID: 7044465
    [Abstract] [Full Text] [Related]

  • 16. [The use of Vasaprostan (prostaglandin E1) in treating patients with obliterating arterial diseases of the lower extremities].
    Lebedev LV, Afonin DN.
    Vestn Khir Im I I Grek; 1993 Jun 08; 150(5-6):153-7. PubMed ID: 8091569
    [No Abstract] [Full Text] [Related]

  • 17. Hemodynamic effects of intravenous PGE1 on patients with arterial occlusive disease of the leg.
    Hirai M, Nanki M, Nakayama R.
    Angiology; 1985 Jul 08; 36(7):407-13. PubMed ID: 4040721
    [Abstract] [Full Text] [Related]

  • 18. Reaction of transcutaneous PO2 and laser Doppler flow signal on intraarterial infusion of PGE1 and nucleotide phosphates in patients with peripheral arterial occlusive disease.
    Caspary L, Creutzig A, Alexander K.
    Vasa Suppl; 1987 Jul 08; 17():17-22. PubMed ID: 3470960
    [No Abstract] [Full Text] [Related]

  • 19. [Role and place of prolonged intra-arterial infusion in the treatment of obliterating arterial diseases of the lower extremities].
    Belichenko IA, Kungurtsev VV, Dibirov MD.
    Khirurgiia (Mosk); 1980 Mar 08; (3):48-51. PubMed ID: 7366097
    [No Abstract] [Full Text] [Related]

  • 20. [Long-term blood pressure measurements with i.v. prostaglandin E1 infusion].
    Heidrich H, Brodel C, Meuche C, Hellmann G, Ranft J.
    Vasa Suppl; 1989 Mar 08; 27():46. PubMed ID: 2623542
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.